A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

This study is currently recruiting participants.
Verified April 2013 by Eli Lilly and Company
Sponsor:
Collaborator:
Mayo Clinic
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01632306
First received: June 28, 2012
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)